CAAS Capital Management’s Lux Health Tech Acquisition Corp. Class A Common Stock LUXA Stock Holding History

CAAS Capital Management’s Portfolio LUXA Stock Details LUXA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-52,200	Closed	-$523K	–	1104
2022 Q3	$523K	Hold	52,200	–	–	0.03%	486
2022 Q2	$516K	Buy	+52,200	New	+$515K	0.03%	515
2021 Q3	–	Sell	-86,802	Closed	-$858K	–	1275
2021 Q2	$858K	Sell	86,802 -29,989	-26%	-$302K	0.01%	623
2021 Q1	$1.2M	Sell	116,791 -33,209	-22%	-$369K	0.01%	746
2020 Q4	$1.61M	Buy	+150,000	New	+$1.61M	0.02%	530

CAAS Capital Management's LUXA Position: Q4 2022 in Review

CAAS Capital Management sold out of Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) in Q4 2022, closing a stake of 52,200 shares — an estimated $523K sold.

CAAS Capital Management first reported a position in LUXA in Q4 2020 and held it in 5 quarters. The position peaked at $1.61M in Q4 2020. 0 funds tracked by Wall St. Rank hold LUXA as of Q4 2022.

CAAS Capital Management reported no remaining Lux Health Tech Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
CAAS Capital Management sold 52,200 Lux Health Tech Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $523K.
CAAS Capital Management first reported a position in Lux Health Tech Acquisition Corp. Class A Common Stock in Q4 2020 and held it in 5 quarters.
CAAS Capital Management's Lux Health Tech Acquisition Corp. Class A Common Stock position peaked at $1.61M in Q4 2020.
0 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on CAAS Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.